Is AI the only practical solution to more sustainable operations?

Distilling new insights from a recent podcast with an industry investor from Nordic Capital, ArisGlobal CEO Aman Wasan makes a robust financial case for advanced automation in processing pharma’s multiplying regulatory and safety workloads. 

For life science R&D organisations to have a sustainable financial future, those companies must be in a position to maintain or grow profit while minimising the impact of significant and converging market pressures.  

Economically and commercially, those pressures range from high interest rates and soaring costs, to increased global supply…